Tag Archives: BSRR

Top 5 Blue Chip Stocks To Watch Right Now

The literary world is facing difficult questions about how it will move forward in the age of #MeToo after allegations of misconduct and verbal abuse were made against a Pulitzer Prize-winning author.

The accusations against Junot D铆az, who won the 2008 Pulitzer Prize for fiction for his novel “The Brief Wondrous Life of Oscar Wao,” were detailed during an exchange at a writers’ event and statements made on social media by multiple female authors, weeks after D铆az published a hailed essay about the repeated instances of sexual assault he endured as a child and the decades he’s spent dealing with the emotional aftermath.

CNN has been unable to verify the accusers’ claims, those in the literary community — from authors to booksellers — have spent the days since the allegations surfaced on Friday facing questions adjacent to those tackled by the entertainment industry when a string of sexual harassment and misconduct allegations were made against several prominent figures late last year, particularly whether or not to standby the accused.

Top 5 Blue Chip Stocks To Watch Right Now: Pacific Biosciences of California Inc.(PACB)

Pacific Biosciences of California, Inc., a development stage company, develops, manufactures, and markets an integrated platform for genetic analysis. The company engages in developing a technology platform that enables single molecule, real-time (SMRT) for the detection of biological processes. It primarily focuses on the deoxyribonucleic acid sequencing market. The company?s product includes the PacBio RS, a sequencing platform, which consists of an instrument platform that uses its proprietary consumables, such as SMRT Cells and reagent kits. The company?s customers include genome centers, genomics service providers, and agricultural companies, as well as clinical, government, and academic institutions. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.

Advisors’ Opinion:

  • [By Keith Speights]

    Illumina announced in November that it plans to acquire Pacific Biosciences of California (NASDAQ:PACB), frequently referred to as PacBio, for $1.2 billion. The move paves the way for Illumina to get its foot in the door in the long-read sequencing market.

  • [By Joseph Griffin]

    Pacific Biosciences of California (NASDAQ:PACB)’s share price traded up 2.3% during mid-day trading on Friday . The company traded as high as $5.82 and last traded at $5.42. 66,454 shares traded hands during trading, a decline of 95% from the average session volume of 1,471,044 shares. The stock had previously closed at $5.55.

  • [By Logan Wallace]

    Shares of Pacific Biosciences of California (NASDAQ:PACB) gapped up prior to trading on Thursday . The stock had previously closed at $4.99, but opened at $4.87. Pacific Biosciences of California shares last traded at $5.16, with a volume of 170693 shares traded.

Top 5 Blue Chip Stocks To Watch Right Now: Bio-Rad Laboratories, Inc.(BIO.B)

Bio-Rad Laboratories, Inc. (Bio-Rad), incorporated on March 10, 1975, is a manufacturer and distributor of life science research and clinical diagnostics products. The Company manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Bio-Rad operates in two segments: Life Science and Clinical Diagnostics. The Company’s Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Company’s Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. Bio-Rad sells over 8,000 products and services to a client base consisting of scientific research, healthcare, education and government customers around the world.

Life Science

The Company’s Life Science segment markets and develops, manufactures and markets a range of over 5,000 reagents, apparatus and laboratory instruments that serve a global customer base. Its products are used in established research techniques, biopharmaceutical production processes and food testing regimes. These techniques are used to separate, purify and identify biological materials, such as proteins, nucleic acids and bacteria within a laboratory or production setting. The Company focuses on selected segments of the life sciences market in proteomics (the study of proteins), genomics (the study of genes), biopharmaceutical production, cell biology and food safety. Its life science customers include universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers and food testing laboratories.

Clinical Diagnostics

The Company’s Clinical Diagnostic! s segment offers products that serve clinical laboratories in the global diagnostics market. Its products address the in vitro diagnostics (IVD) test market. The Company supplies over 3,000 different products that cover approximately 300 clinical diagnostic tests to the IVD test market. IVD tests are conducted outside the human body and are used to identify and measure substances in a patient’s tissue, blood or urine. The Company’s products consist of reagents, instruments and software, typically provided to its customers as an integrated package to allow them to generate reproducible test results. Its principal clinical diagnostic customers include hospital laboratories, reference laboratories, transfusion laboratories and physician office laboratories.

The Company competes with GE Biosciences, Merck Millipore, Thermo Fisher Scientific, Roche, Abbott Laboratories, Siemens, Danaher, Becton Dickinson, bioMerieux, Ortho Clinical Diagnostics, Tosoh, Immucor and DiaSorin.

Advisors’ Opinion:

  • [By Joseph Griffin]

    Bio-Rad Laboratories (NYSE:BIO.B) and Quanterix (NASDAQ:QTRX) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

Top 5 Blue Chip Stocks To Watch Right Now: Cliffs Natural Resources Inc.(CLF)

Cliffs Natural Resources Inc., a mining and natural resources company, produces iron ore pellets, lump and fines iron ore, and metallurgical coal products. The company operates six iron ore mines in Michigan, Minnesota, and eastern Canada; two iron ore mining complexes in Western Australia; five metallurgical coal mines located in West Virginia and Alabama; and one thermal coal mine located in West Virginia. It also owns a 45% economic interest in a coking and thermal coal mine located in Queensland, Australia; and a 30% interest in Amapa, a Brazilian iron ore project in Latin America, as well as chromite properties in Ontario, Canada. The company, formerly known as Cleveland-Cliffs Inc, was founded in 1847 and is headquartered in Cleveland, Ohio.

Advisors’ Opinion:

  • [By Tyler Crowe, Sean Williams, and Brian Stoffel]

    So we asked three Motley Fool contributors to each highlight a stock they see as a great value investment today. Here’s why they picked Walmart (NYSE:WMT), Bank of America (NYSE:BAC), and Cleveland-Cliffs (NYSE:CLF).

  • [By Shane Hupp]

    Shares of Cleveland-Cliffs Inc (NYSE:CLF) have been given an average recommendation of “Hold” by the fifteen analysts that are presently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $11.80.

  • [By John Bromels, Rich Smith, and Tyler Crowe]

    We asked three of our Motley Fool contributors to pick out a mining stock they think is poised to outperform, and they came back with iron minerCleveland-Cliffs(NYSE:CLF), precious metals streaming companyWheaton Precious Metals(NYSE:WPM), and Warren Buffett’sBerkshire Hathaway(NYSE:BRK-A)(NYSE:BRK-B). Yes, you read that right: Berkshire Hathaway. Here’s why they think these mining stocks might be right for your portfolio.

  • [By Lee Jackson]

    Jefferies likes this top mining play. Cleveland-Cliffs Inc. (NYSE: CLF) is a mining and natural resources company. It is a supplier of iron ore pellets to the North American steel industry from its mines and pellet plants located in Michigan and Minnesota. The company’s segments include U.S. Iron Ore and Asia Pacific Iron Ore. Operations of the latter are located in Western Australia and consist of its Koolyanobbing operation.

Top 5 Blue Chip Stocks To Watch Right Now: Kaman Corporation(KAMN)

Kaman Corporation, headquartered in Bloomfield, Connecticut, was incorporated in 1945. We are a diversified company that conducts business in the aerospace and distribution markets. We report information for ourselves and our subsidiaries (collectively, “we,” “us,” “our,” and “the Company”) in two business segments, Distribution and Aerospace. A discussion of 2015 developments is included in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, in this Form 10-K.
Distribution Segment
The Distribution segment brings our commitment to technological leadership and value-added services to the distribution business. The Distribution segment is a leading power transmission, motion control, electrical and automation, and fluid power industrial distributor with operations throughout the United States.   Advisors’ Opinion:

  • [By Joseph Griffin]

    Laurion Capital Management LP purchased a new position in shares of Kaman Co. (NYSE:KAMN) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 17,114 shares of the industrial products company’s stock, valued at approximately $1,192,000. Laurion Capital Management LP owned about 0.06% of Kaman as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Kaman (KAMN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Kaman (KAMN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Kaman Aircraft (NYSE:KAMN) hit a new 52-week high and low on Wednesday . The stock traded as low as $67.95 and last traded at $68.00, with a volume of 2807 shares traded. The stock had previously closed at $67.07.

Top 5 Blue Chip Stocks To Watch Right Now: Sierra Bancorp(BSRR)

Sierra Bancorp, incorporated on November 16, 2000, is a bank holding company for Bank of the Sierra (the Bank). The Bank is a state-chartered bank, which offers a range of retail and commercial banking services. The Bank’s products and services are related to the business of lending money and accepting deposits. The Bank operates approximately 30 branch offices, an online branch, a real estate industries group, an agricultural credit division, a Small Business Administration (SBA) lending unit and a loan production office. Its customers have access to electronic point-of-sale payment alternatives around the country through the Pulse Electronic Funds Transfer (EFT) network. Its Internet branch provides the ability to open deposit accounts online; an online banking option with bill-pay and mobile banking capabilities, including mobile check deposit; a customer service center that is accessible by toll-free telephone during business hours, and an automated telephone banking system. It offers a range of other banking products and services to complement and support its lending and deposit products, including remote deposit capture and automated payroll services for business customers. The Company’s other direct subsidiaries are Sierra Statutory Trust II and Sierra Capital Trust III, which are engaged in facilitating the issuance of capital trust pass-through securities.

Lending Activities

The Bank’s lending activities include real estate, commercial (including small business), agricultural and consumer loans. The bulk of its real estate loans are secured by commercial, professional office properties and agricultural properties, which are owner occupied. The Bank also offers a range of construction loans for residential and commercial development, permanent mortgage loans, land acquisition and development loans, and multifamily credit facilities. Secondary market services for residential mortgage loans are provided through the Bank’s affiliations with Freddie Mac, Fannie Mae and ce! rtain non-governmental institutions. The Bank’s total net loans are approximately $1,124.6 million.

Investment Activities

The Bank’s investments consist of debt and marketable equity securities (together, the investment portfolio), investments in the time deposits of other banks, surplus interest-earning balances in its Federal Reserve Bank account and overnight fed funds sold. The Bank’s securities are all marketable and are classified as available for sale, which include the United States Government agencies, mortgage-backed securities, state and political subdivisions, and equity securities. The Bank’s aggregate investments are approximately $510 million.

Sources of Funds

The Bank offers a range of deposit products for individuals and businesses, including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts and sweep accounts. The Bank’s non-maturity deposits include demand deposit accounts and negotiable order of withdrawal (NOW) accounts. The Bank has approximately 101,200 deposit accounts totaling over $1,465 billion. The Bank’s non-deposit borrowings include fed funds purchased from correspondent banks, borrowings from the Federal Home Loan Bank (FHLB), advances from the Federal Reserve Bank, securities sold under agreement to repurchase and junior subordinated debentures. The Bank uses short-term FHLB advances and fed funds purchased on uncommitted lines to support liquidity needs created by seasonal deposit flows and for other short-term purposes.

Advisors’ Opinion:

  • [By Shane Hupp]

    Sierra Bancorp (NASDAQ:BSRR) was downgraded by BidaskClub from a “hold” rating to a “sell” rating in a report released on Friday.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Sierra Bancorp (BSRR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Sierra Bancorp (NASDAQ:BSRR) and ServisFirst Bancshares (NASDAQ:SFBS) are both finance companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, risk, valuation, institutional ownership, analyst recommendations and earnings.

  • [By Shane Hupp]

    Sierra Bancorp (NASDAQ:BSRR) has been assigned a consensus recommendation of “Hold” from the seven analysts that are covering the stock, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $31.00.